
Sgltd-Trio 10mg/500mg/100mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Sgltd-Trio 10mg/500mg/100mg Tablet
Tri-Glycemic 10/500/100mg tablets combine three medications to manage blood glucose. This regimen, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Tri-Glycemic 10/500/100mg can be ingested with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuing use without consulting your doctor may elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication complements a comprehensive treatment plan, incorporating healthy eating, regular physical activity, and weight management as recommended by your doctor. Common side effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration is crucial to prevent dehydration. Genital yeast infections are a possibility; good hygiene practices can mitigate this risk. Prior to starting Tri-Glycemic 10/500/100mg, disclose any pre-existing kidney or liver disease, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating women should seek medical advice before use. Limit alcohol consumption while on this medication to minimize potential adverse reactions. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Sgltd-Trio 10mg/500mg/100mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Sgltd-Trio 10mg/500mg/100mg Tablet
Managing type 2 diabetes
Major Benefits of Sgltd-Trio 10mg/500mg/100mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the Sgltd-Trio 10mg/500mg/100mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently; however, consistent daily timing is recommended.
Common Side effects of Sgltd-Trio 10mg/500mg/100mg Tablet:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Sgltd-Trio 10mg/500mg/100mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Sgltd-Trio 10mg/500mg/100mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent daily timing is recommended.
How Sgltd-Trio 10mg/500mg/100mg Tablet works:
Sglt2-Inhibitor/Metformin/DPP-4 Inhibitor Triple Therapy (10mg/500mg/100mg) combines three agents to manage blood glucose. Dapagliflozin promotes glucose elimination via the kidneys, lowering blood sugar. Metformin reduces glucose absorption from food, diminishes hepatic glucose production, and enhances insulin sensitivity. Sitagliptin boosts incretin levels, stimulating insulin release from the pancreas and suppressing excess hepatic glucose production.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sgltd-Trio 10mg/500mg/100mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of Sgltd-Trio 10mg/500mg/100mg tablets are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of breastfeeding while taking Sglt2-inhibitor/metformin/pioglitazone 10mg/500mg/100mg tablets is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Sgltd-Trio 10mg/500mg/100mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sglt2-inhibitor/metformin/dapagliflozin combination tablets (10mg/500mg/100mg) in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sgltd-Trio 10mg/500mg/100mg tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Sgltd-Trio 10mg/500mg/100mg Tablet :
NA
Facts to Know About Sgltd-Trio 10mg/500mg/100mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
